100 related articles for article (PubMed ID: 286100)
1. A tumor-associated organ-specific antigen characteristic of spontaneously metastatic rat mammary carcinomas.
Ghosh SK; Grossberg AL; Kim U; Pressman D
J Natl Cancer Inst; 1979 May; 62(5):1229-33. PubMed ID: 286100
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
North SM; Steck PA; Nicolson GL
Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MT-450 rat mammary tumour growth by antibodies recognising subtypes of blood group antigen B.
Sleeman JP; Kim U; LePendu J; Howells N; Coquerelle T; Ponta H; Herrlich P
Oncogene; 1999 Aug; 18(31):4485-94. PubMed ID: 10442639
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside profiles of metastases and of metastasizing and nonmetastasizing rat primary mammary carcinomas.
Skipski VP; Carter SP; Terebus-Kekish OI; Podlaski FJ; Peterson RH; Stock CC
J Natl Cancer Inst; 1981 Dec; 67(6):1251-8. PubMed ID: 6947108
[TBL] [Abstract][Full Text] [Related]
5. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies.
Nicolson GL; Lembo TM; Welch DR
Cancer Res; 1988 Jan; 48(2):399-404. PubMed ID: 2825974
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
7. Lack of production of myoepithelial variants by cloned epithelial cell lines derived from the TMT-081 metastasizing rat mammary tumor.
Dunnington DJ; Kim U; Hughes CM; Monaghan P; Rudland PS
Cancer Res; 1984 Nov; 44(11):5338-46. PubMed ID: 6488188
[TBL] [Abstract][Full Text] [Related]
8. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
9. Presence of a specific immune complex in the cell-free ascites of a spontaneously metastasizing rat mammary adenocarcinoma, TMT-081.
Ghosh SK; Roholt OA
Immunol Commun; 1984; 13(1):63-76. PubMed ID: 6735434
[TBL] [Abstract][Full Text] [Related]
10. Cross-reacting tumor-associated antigen(s) of adenovirus type 9-induced fibroadenomas and a chemically induced mammary carcinoma in rats.
Ankerst J; Steele G; Sjögren HO
Cancer Res; 1974 Aug; 34(8):1794-800. PubMed ID: 4367178
[No Abstract] [Full Text] [Related]
11. Loss of myoepithelial cell characteristics in metastasizing rat mammary tumors relative to their nonmetastasizing counterparts.
Dunnington DJ; Kim U; Hughes CM; Monaghan P; Ormerod EJ; Rudland PS
J Natl Cancer Inst; 1984 Feb; 72(2):455-66. PubMed ID: 6198552
[TBL] [Abstract][Full Text] [Related]
12. Cross-reacting tumor-associated antigen (s) among chemically induced rat colon carcinomas.
Steele G; Sjögren HO
Cancer Res; 1974 Aug; 34(8):1801-7. PubMed ID: 4366501
[No Abstract] [Full Text] [Related]
13. Circulating immune complexes in rats bearing 6-thioguanine-resistant variants of the 13762 mammary adenocarcinoma.
Hoon DB; Ziola B; Ramshaw I
Cancer Res; 1984 Jun; 44(6):2406-9. PubMed ID: 6722781
[TBL] [Abstract][Full Text] [Related]
14. N-nitroso-N-methylurea-induced mammary carcinogenesis: effect of prolactin on expression of Ia antigen by tumor cells.
Bernard DJ; Maurizis JC; Chassagne J; Chollet P; Plagne R
J Natl Cancer Inst; 1986 Jun; 76(6):1237-42. PubMed ID: 3012179
[TBL] [Abstract][Full Text] [Related]
15. Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice.
Yamazaki M; Akahane T; Buck T; Yoshiji H; Gomez DE; Schoeffner DJ; Okajima E; Harris SR; Bunce OR; Thorgeirsson SS; Thorgeirsson UP
Carcinogenesis; 2004 Sep; 25(9):1735-46. PubMed ID: 15166086
[TBL] [Abstract][Full Text] [Related]
16. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats.
Chen WR; Liu H; Ritchey JW; Bartels KE; Lucroy MD; Nordquist RE
Cancer Res; 2002 Aug; 62(15):4295-9. PubMed ID: 12154032
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages of mouse mammary tumors. II. Differential distribution of macrophages from metastatic and nonmetastatic tumors.
Mahoney KH; Fulton AM; Heppner GH
J Immunol; 1983 Oct; 131(4):2079-85. PubMed ID: 6311907
[TBL] [Abstract][Full Text] [Related]
18. Differences in the responsiveness of splenic, lymph node, and peripheral blood lymphoid cells to tumor membrane extracts.
Krueger JG; Segal RA; Moyer RC
Cancer Res; 1977 Jan; 37(1):320-2. PubMed ID: 830419
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis and characteristics of spontaneously metastasizing mammary carcinomas and the general principle of metastasis.
Kim U
J Surg Oncol; 1986 Nov; 33(3):151-65. PubMed ID: 3095592
[TBL] [Abstract][Full Text] [Related]
20. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
Lopez PF; Parks WP; Lopez DM
J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
